The BIOFIRE RP2.1 Panel is a frontline test to help clinicians more quickly diagnose URTIs, including COVID-19, influenza, RSV, and many others. The multiplex PCR panel identifies 22 …

BioFire’s syndromic approach combines a broad grouping of probable pathogens into a single, rapid test. With the BioFire RP2.1plus Panel, all it takes is one test and just 45 minutes to …

The cobas® eplex RP2 panel is intended for the detection and differentiation of nucleic acid from SARS-CoV-2 and the following virus types, subtypes, and bacteria: adenovirus, coronavirus …

The BioFire RP2.1 Panel uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections. Fast and comprehensive, …

The BIOFIRE RP2.1 and RP2.1plus Panels use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive …

BioFire RP2.1 are designed to detect RNA from the SARS-CoV-2 in nasopharyngeal swabs in transport media from patients who are suspected of COVID-19. Internal controls are used to …

The BioFire Respiratory Panel 2.1 (RP2.1) is a PCR-based multiplexed nucleic acid test intended for use with the BioFire® 2.0 or BioFire® Torch Systems for the simultaneous qualitative …

Learn more about the BIOFIRE range of commercially-available panels for syndromic infectious disease diagnostics. Scan the QR code for more information. Product availability varies by …

The BioFire RP2.1/RP2.1plus Control Panel M441 is intended for in vitro use as reference material to monitor the detection and identification of respiratory viral and bacterial targets in …

NATtrol™ Respiratory Panel 2.1 (RP2.1) Controls (qualitative) is formulated with purified, intact bacterial cells and viral particles. The microorganisms have been chemically modified to …